Urgent Cancer Medicine For Doug Murcott

A study recently unveiled by the American Epilepsy Society (AES) has found a cannabis derivative to be effective in combating epilepsy, with the substance exhibiting acute efficacy in treating the condition within children.

The study – titled “Efficacy and Safety of Epidiolex (Cannabidiol) in Children and Young Adults With Treatment-Resistant Epilepsy” – was unveiled at the AES’s 70th annual meeting last month.

The study found that cannabidiol (CBD) was effective in reducing both the frequency and severity of seizures in both children and adults. It began in Philadelphia in 2014 with children from epilepsy treatment centers nationwide.

Specifically, patients who received the treatment were found to have exhibited a median reduction in seizures of 45.1 percent.

The study was unequivocal in its findings...leaving no doubt.